These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38963486)

  • 1. Oligomerization of Monoamine Transporters.
    Paul A; Shukla D
    Subcell Biochem; 2024; 104():119-137. PubMed ID: 38963486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine transporters: structure, intrinsic dynamics and allosteric regulation.
    Cheng MH; Bahar I
    Nat Struct Mol Biol; 2019 Jul; 26(7):545-556. PubMed ID: 31270469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidation of structural elements for selectivity across monoamine transporters: novel 2-[(diphenylmethyl)sulfinyl]acetamide (modafinil) analogues.
    Okunola-Bakare OM; Cao J; Kopajtic T; Katz JL; Loland CJ; Shi L; Newman AH
    J Med Chem; 2014 Feb; 57(3):1000-13. PubMed ID: 24494745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Putative drug binding conformations of monoamine transporters.
    Ravna AW; Sylte I; Kristiansen K; Dahl SG
    Bioorg Med Chem; 2006 Feb; 14(3):666-75. PubMed ID: 16216517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats.
    Conti MM; Meadows SM; Melikhov-Sosin M; Lindenbach D; Hallmark J; Werner DF; Bishop C
    Neuropharmacology; 2016 Nov; 110(Pt A):125-134. PubMed ID: 27452719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to rescue misfolded SERT, DAT and NET: targeting conformational intermediates with atypical inhibitors and partial releasers.
    Bhat S; Newman AH; Freissmuth M
    Biochem Soc Trans; 2019 Jun; 47(3):861-874. PubMed ID: 31064865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human genetics and pharmacology of neurotransmitter transporters.
    Lin Z; Madras BK
    Handb Exp Pharmacol; 2006; (175):327-71. PubMed ID: 16722243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Handling of intracellular K
    Bhat S; Niello M; Schicker K; Pifl C; Sitte HH; Freissmuth M; Sandtner W
    Elife; 2021 Jun; 10():. PubMed ID: 34061030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloride requirement for monoamine transporters.
    De Felice LJ
    Pflugers Arch; 2016 Mar; 468(3):503-11. PubMed ID: 26794730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and monoamine transporter affinity of front bridged tricyclic 3beta-(4'-halo or 4'-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2beta-position.
    Zeng F; Jarkas N; Owens MJ; Kilts CD; Nemeroff CB; Goodman MM
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4661-3. PubMed ID: 16784855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.
    Han DD; Gu HH
    BMC Pharmacol; 2006 Mar; 6():6. PubMed ID: 16515684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α
    Halberstadt AL; Brandt SD; Walther D; Baumann MH
    Psychopharmacology (Berl); 2019 Mar; 236(3):989-999. PubMed ID: 30904940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters.
    Zhang S; Fernandez F; Hazeldine S; Deschamps J; Zhen J; Reith ME; Dutta AK
    J Med Chem; 2006 Jul; 49(14):4239-47. PubMed ID: 16821783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative modeling of the human monoamine transporters: similarities in substrate binding.
    Koldsø H; Christiansen AB; Sinning S; Schiøtt B
    ACS Chem Neurosci; 2013 Feb; 4(2):295-309. PubMed ID: 23421681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
    Pifl C; Reither H; Hornykiewicz O
    Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
    Verrico CD; Miller GM; Madras BK
    Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordination of Na(+) by monoamine ligands in dopamine, norepinephrine, and serotonin transporters.
    Xhaard H; Backström V; Denessiouk K; Johnson MS
    J Chem Inf Model; 2008 Jul; 48(7):1423-37. PubMed ID: 18543980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A kinome wide screen identifies novel kinases involved in regulation of monoamine transporter function.
    Vuorenpää A; Ammendrup-Johnsen I; Jørgensen TN; Gether U
    Neurochem Int; 2016 Sep; 98():103-14. PubMed ID: 27020406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The extracts of Fructus Akebiae, a preparation containing 90% of the active ingredient hederagenin: serotonin, norepinephrine and dopamine reuptake inhibitor.
    Jin ZL; Gao N; Zhou D; Chi MG; Yang XM; Xu JP
    Pharmacol Biochem Behav; 2012 Jan; 100(3):431-9. PubMed ID: 22005599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes.
    Xie Z; Westmoreland SV; Miller GM
    J Pharmacol Exp Ther; 2008 May; 325(2):629-40. PubMed ID: 18310473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.